PI-FC

Serial Number 79283542
Registration 6187420
700

Registration Progress

Application Filed
Jan 22, 2020
Under Examination
Approved for Publication
Aug 18, 2020
Published for Opposition
Aug 18, 2020
Registered
Nov 3, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-11-03)
Due: Nov 03, 2026 359 days

Trademark Image

PI-FC

Basic Information

Serial Number
79283542
Registration Number
6187420
Filing Date
January 22, 2020
Registration Date
November 3, 2020
Published for Opposition
August 18, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 3, 2020
Registration
Registered
Classes
005 042 045

Rights Holder

CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)

03
Address
5-1, Ukima 5-Chome
Kita-Ku Tokyo 115-8543
JP

Ownership History

CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)

Original Applicant
03
JP

CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)

Owner at Publication
03
JP

CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)

Original Registrant
03
JP

Legal Representation

Attorney
Bassam N. Ibrahim

USPTO Deadlines

Next Deadline
359 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-11-03)
Due Date
November 03, 2026
Grace Period Ends
May 03, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Nov 3, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Mar 21, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 17, 2021 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Feb 17, 2021 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Feb 3, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 3, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 18, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 18, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 29, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 13, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 29, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 29, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 29, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 22, 2020 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Jun 17, 2020 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Loading...
Jun 15, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 15, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 15, 2020 ALIE A ASSIGNED TO LIE Loading...
Jun 12, 2020 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Jun 5, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 4, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 4, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 4, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jun 4, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 4, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 4, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 29, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
May 2, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 2, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 24, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 23, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 22, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 16, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use to enhance efficiency of soluble antigen elimination from plasma, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for medical and pharmaceutical use
Class 042
Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
Class 045
Granting of licenses to others for the use of industrial property rights and copyrights

Classification

International Classes
005 042 045